BioIntelliSense, Inc.

@MethodistHosp study shows BioButton® continuous monitoring cut ICU mortality risk 27% in high-risk patients—catching deterioration hours earlier. Published in Journal of Clinical Medicine. Explore the findings: mdpi.com/2077-0383/14/2…

This Sunday is #NationalDoctorsDay! At BioIntelliSense, we are honored to support the doctors at the intersection of patient care & innovation—and proud to work with them hand-in-hand to enhance patient safety and improve patient outcomes with continuous patient monitoring.

BioIntelliSense & @HicuityHealth are redefining continuous patient monitoring with a scalable, end-to-end virtual care solution that extends from in-hospital to home. Learn how our new partnership is helping resolve critical infrastructure & staffing challenges for hospitals:

At @MethodistHosp, the FDA-cleared BioButton® for continuous patient monitoring is about more than improved workflow – it’s about enabling improved safety and outcomes for patients. Read more in @HealthLeaders: healthleadersmedia.com/cno/how-nurses…

Healthcare can be continuous & effective across care settings. The FDA-cleared BioButton® keeps providers informed & patients at ease, enabling proactive care from in-hospital to home. Lightweight, rechargeable, & trusted by thousands for data-driven care. biointellisense.com

#ViVE25 reminded us why we’re passionate about supporting nurses and clinical teams. Thank you for sharing your priorities and challenges—your dedication inspires us. Missed us at ViVE? Let’s connect: biointellisense.com/contact #ViVE2025 #NursingInnovation #BioButtonWearable

At #ViVE2025, Sarah Pletcher, MD, of @MethodistHosp shares how continuous vitals monitoring using the BioButton® wearable device is enabling more proactive, data-driven care across all nine of their hospitals. #NursingInnovation #ContinuousMonitoring

We're proudly partnering with @HicuityHealth to bring 24/7 virtual patient monitoring to U.S. hospitals, easing staffing challenges & clinical burdens. Read more about how we are enhancing patient care w/medical-grade monitoring across settings: apnews.com/press-release/…

Headed to #ViVE2025? Visit us at booth #2438-5 in the Nurse’s Pavilion to learn how the FDA-cleared BioButton® is helping nurses save time, reduce repetitive tasks, and focus on patient care: biointellisense.com/vive #NursingInnovation #HealthTech

The BioButton® is transforming healthcare. Join our CEO James Mault, MD, at #ViVE25 on Feb 18, 10:50 am CT, as he discusses “Delivering on the Promise of Wearable Tech” with @rhapsodyhealth. Learn more: biointellisense.com/vive #HealthTech #ContinuousMonitoring

Learn more and schedule a demo here: biointellisense.com/vive [2/2]

We’re heading to #ViVE25! Join us in Nashville, Feb 16-19, to see how the BioButton® makes patient monitoring continuous and scalable. Visit booth #2438-5 & don’t miss CEO James Mault, MD's talk, "Delivering on the Promise of Wearable Tech," Feb 18, 10:50am CT. #HealthTech [1/2]

The FDA-cleared BioButton® wearable for continuous monitoring helps improve patient outcomes and peace-of-mind for nurses. In their own words: Hear how the BioButton at @MethodistHosp measures up from nurses on the front lines.

New peer-reviewed research in the @JCM_MDPI underscores the transformational power of the BioIntelliSense medical-grade BioButton® wearable device and clinical intelligence solution for continuous patient monitoring at scale. Explore the top findings🔽

We're proud and honored to be part of this important mission, and to help advance our collective understanding of health here on Earth and now in #space!

Mark your calendars! BioIntelliSense CEO James Mault, MD joins the #AHA24 Scientific Sessions panel, “AI Everywhere: Transforming Healthcare from Diagnostics to Virtual Care.” Sat, Nov 16, 3:55-4:30 PM #AIinHealthcare #HealthTech #ContinuousMonitoring

With health systems facing budget and staffing pressures, the FDA-cleared BioButton® Multi-Patient Wearable offers a cost-effective, reliable continuous monitoring solution for general care settings, including Hospital@Home care. Learn more: BioIntelliSense.com

We’re thrilled that @FierceHealth selected the medical-grade BioButton® device as a finalist in the 2024 #FierceInnovationAwards. This honor is a testament to the hard work and ingenuity of the BioIntelliSense team and the incredible nurses on the front lines of patient care.

“We’re going to look back on this decade as one of the most profound moments in human healthcare.” – BioIntelliSense Founder & CEO Dr. James Mault shared his vision for the future of healthcare at @adghwofficial. Click play for more on the new era in care.

Register for #DigitalHealthontheHill using this link by September 12th to hear Carolyn showcase the new standard of continuous care during the panel session ‘Screening for Success: ROI of Digital Health Interventions.’ 🔽 bit.ly/3MGvIzY [2/2]

Next Thursday, BioIntelliSense CCO Carolyn Walsh heads to @EY’s Digital Health on the Hill to meet w/ industry leaders & lawmakers. She’ll share how wireless, multiparameter wearables like the medical-grade BioButton® keep patients connected to care from hospital to home. [1/2]